MedPath

Jiangsu Province Centers for Disease Control and Prevention

People's Republic of China
Ownership
Private
Employees
-
Market Cap
-
Website
http://www.jstd.gov.cn/

Study of Evaluating Safety and Immunogenicity of 10µg/0.5ml Hepatitis B Vaccine

Phase 3
Completed
Conditions
Hepatitis B
Interventions
Biological: 3 dose of 10µg/0.5ml hepatitis B vaccine
Biological: 3 dose of 5µg/0.5ml hepatitis B vaccine
First Posted Date
2014-06-02
Last Posted Date
2014-06-02
Lead Sponsor
Jiangsu Province Centers for Disease Control and Prevention
Target Recruit Count
1537
Registration Number
NCT02152709
Locations
🇨🇳

Jiangsu Provincial Center for Disease Control and Prevention, Nanjing, Jiangsu, China

Study of Evaluating Safety and Immunogenicity of 23-Valent Pneumococcal Polysaccharide Vaccine With Influenza Vaccine in Children and Adults

Phase 4
Completed
Conditions
Pneumococcal Infection
Influenza
Interventions
Biological: 23-valent pneumococcal polysaccharide vaccine
Biological: trivalent influenza vaccine
Biological: 23vPPV+TIV
First Posted Date
2014-02-13
Last Posted Date
2014-02-13
Lead Sponsor
Jiangsu Province Centers for Disease Control and Prevention
Target Recruit Count
2225
Registration Number
NCT02062281
Locations
🇨🇳

Yangzhong Center for Disease Control and Prevention, Zhenjiang, Jiangsu, China

The Study of KAP on Drink Driving in Jiangsu Province in China

Completed
Conditions
Drink Driving
Interventions
Behavioral: health education & law enforcement
First Posted Date
2014-02-13
Last Posted Date
2016-09-01
Lead Sponsor
Jiangsu Province Centers for Disease Control and Prevention
Target Recruit Count
3565
Registration Number
NCT02062268
Locations
🇨🇳

Jiangsu Provincial Center for Disease Control and Prevention, Nanjing, Jiangsu, China

Safety of H1N1 Influenza Vaccination in Pregnant Women

Phase 4
Completed
Conditions
Virus Diseases
Respiratory Tract Infections
Influenza
Orthomyxoviridae Infections
Interventions
Biological: split-virion, non-adjuvanted H1N1 vaccine of 15 μg
First Posted Date
2013-04-30
Last Posted Date
2013-04-30
Lead Sponsor
Jiangsu Province Centers for Disease Control and Prevention
Target Recruit Count
122
Registration Number
NCT01842997
Locations
🇨🇳

Xiangshui Center for Disease Control and Prevention, Xiangshui, Jiangsu, China

A Booster Dose of Inactivated Vaccine (Vero Cell) Against EV71 in Chinese Children

Phase 2
Completed
Conditions
EV71-associated Disease
Interventions
Biological: 0/0.5ml placebo
Biological: alum-adjuvant 160U /0.5ml
Biological: adjuvant-free 640U /0.5ml
Biological: alum-adjuvant 320U /0.5ml
Biological: alum-adjuvant 640U /0.5ml
First Posted Date
2012-11-27
Last Posted Date
2013-10-23
Lead Sponsor
Jiangsu Province Centers for Disease Control and Prevention
Target Recruit Count
773
Registration Number
NCT01734408
Locations
🇨🇳

Jiangsu Provincial Center for Diseases Control and Prevention, Nanjing, Jiangsu, China

Systems Biology of Vaccination for EV71 Vaccine in Humans

Phase 2
Completed
Conditions
Systems Biology
Early Gene
EV71 Vaccine
Interventions
Biological: 320U /0.5ml
Biological: 0/0.5ml placebo
First Posted Date
2012-09-06
Last Posted Date
2013-05-08
Lead Sponsor
Jiangsu Province Centers for Disease Control and Prevention
Target Recruit Count
72
Registration Number
NCT01679665
Locations
🇨🇳

Jiangsu Provincial Center for Diseases Control and Prevention, Nanjing, Jiangsu, China

A Phase I Clinical Trial With Whole Virus Inactivated Influenza H5N1 Vaccine in Healthy Adolescents and Adults

Phase 1
Withdrawn
Conditions
Healthy
Interventions
Biological: 7.5μg /0.5ml
Biological: 15.0μg /0.5ml
Biological: 30.0μg /0.5ml
Biological: 0/0.5ml placebo
First Posted Date
2012-08-31
Last Posted Date
2013-03-15
Lead Sponsor
Jiangsu Province Centers for Disease Control and Prevention
Registration Number
NCT01676675
Locations
🇨🇳

Jiangsu Provincial Center for Diseases Control and Prevention, Nanjing, Jiangsu, China

Phase 3 Study of A Group A, C Polysaccharide Meningococcal and Type b Haemophilus Influenzal Conjugate Vaccine

Phase 3
Completed
Conditions
Meningitis
Influenza
Interventions
Biological: A+C+hib Conjugate Vaccine
Biological: A+C Vaccine
Biological: Placebo
Biological: Hib vaccine
First Posted Date
2012-04-18
Last Posted Date
2013-05-08
Lead Sponsor
Jiangsu Province Centers for Disease Control and Prevention
Target Recruit Count
900
Registration Number
NCT01580033
Locations
🇨🇳

Funing county Center for Disease Control and Prevention, Yancheng, Jiangsu, China

A Clinical Trial to Assess the Efficacy and Safety of an Inactivated Vaccine (Vero Cell) Against EV71 in Chinese Children Aged 6-35 Months

Phase 3
Completed
Conditions
Hand, Foot and Mouth Disease
Herpangina
Other EV71-associated Diseases
Interventions
Biological: inactivated vaccine (Vero Cell) against EV71
Biological: 0/0.5ml placebo
First Posted Date
2012-01-11
Last Posted Date
2013-03-29
Lead Sponsor
Jiangsu Province Centers for Disease Control and Prevention
Target Recruit Count
10245
Registration Number
NCT01508247
Locations
🇨🇳

Pizhou County-Level City Center for Disease Control and Prevention, Xuzhou, Jiangsu, China

🇨🇳

Donghai County Center for Disease Control and Prevention, Lianyungang, Jiangsu, China

🇨🇳

Baoying County Center for Disease Control and Prevention, Yangzhou, Jiangsu, China

and more 1 locations

Safety and Immunogenicity of 23-valent Pneumococcal Polysaccharide Vaccine in 2 to 70 Years Old Healthy People in China

Phase 3
Completed
Conditions
Healthy
Interventions
Biological: vaccine made by Chengdu Institute of Biological Products
Biological: vaccine made by Beijing Minhai Biotechnology Co., Ltd
First Posted Date
2011-10-13
Last Posted Date
2013-03-15
Lead Sponsor
Jiangsu Province Centers for Disease Control and Prevention
Target Recruit Count
1200
Registration Number
NCT01451086
Locations
🇨🇳

Jiangsu Provincial Center for Diseases Control and Prevention, Nanjing, Jiangsu, China

© Copyright 2025. All Rights Reserved by MedPath